Isaacson Marisa K, Feire Adam L, Compton Teresa
McArdle Laboratory for Cancer Research, University of Wisconsin-Madison Medical School 53706, USA.
J Virol. 2007 Jun;81(12):6241-7. doi: 10.1128/JVI.00169-07. Epub 2007 Apr 11.
Human cytomegalovirus (HCMV) can bind, fuse, and initiate gene expression in a diverse range of vertebrate cell types. This broad cellular tropism suggests that multiple receptors and/or universally distributed receptors mediate HCMV entry. Our laboratory has recently discovered that certain beta1 and beta3 integrin heterodimers are critical mediators of HCMV entry into permissive fibroblasts (A. L. Feire, H. Koss, and T. Compton, Proc. Natl. Acad. Sci. USA 101:15470-15475, 2004). It has also been reported that epidermal growth factor receptor (EGFR) is necessary for HCMV-mediated signaling and entry (X. Wang, S. M. Huong, M. L. Chiu, N. Raab-Traub, and E. E. Huang, Nature 424:456-461, 2003). Integrins are known to signal synergistically with growth factor receptors, and this coordination was recently reported for EGFR and beta3 integrins in the context of HCMV entry (X. Wang, D. Y. Huang, S. M. Huong, and E. S. Huang, Nat. Med. 11:515-521, 2005). However, EGFR-negative cell lines, such as hematopoietic cells, are known to be infected by HCMV. Therefore, we wished to confirm a role for EGFR in HCMV entry and then examine any interaction between beta1 integrins and EGFR during the entry process. Surprisingly, we were unable to detect any role for EGFR in the process of HCMV entry into fibroblast, epithelial, or endothelial cell lines. Additionally, HCMV did not activate the EGFR kinase in fibroblast cell lines. We first examined HCMV entry into two EGFR-positive or -negative cell lines but observed no increase in entry when EGFR was expressed to high levels. Physically blocking EGFR with a neutralizing antibody in fibroblast, epithelial, or endothelial cell lines or blocking EGFR kinase signaling with a chemical inhibitor in fibroblast cells did not inhibit virus entry. Lastly, we were unable to detect phosphorylation of EGFR in fibroblasts cells in response to HCMV stimulation. Our findings demonstrate that EGFR does not play a significant role in HCMV entry or signaling. These results suggest that specific integrin heterodimers either act alone as the primary entry receptors or interact in conjunction with an additional receptor(s), other than EGFR, to facilitate virus entry.
人巨细胞病毒(HCMV)能够在多种脊椎动物细胞类型中结合、融合并启动基因表达。这种广泛的细胞嗜性表明,多种受体和/或普遍分布的受体介导了HCMV的进入。我们实验室最近发现,某些β1和β3整合素异二聚体是HCMV进入允许性成纤维细胞的关键介质(A.L.费雷、H.科斯和T.康普顿,《美国国家科学院院刊》101:15470 - 15475,2004年)。也有报道称,表皮生长因子受体(EGFR)对于HCMV介导的信号传导和进入是必需的(X.王、S.M.胡昂、M.L.邱、N.拉布 - 特劳布和E.E.黄,《自然》424:456 - 461,2003年)。已知整合素与生长因子受体协同发出信号,最近在HCMV进入的背景下报道了EGFR和β3整合素之间的这种协同作用(X.王、D.Y.黄、S.M.胡昂和E.S.黄,《自然医学》11:515 - 521,2005年)。然而,已知造血细胞等EGFR阴性细胞系会被HCMV感染。因此,我们希望确认EGFR在HCMV进入中的作用,然后研究在进入过程中β1整合素与EGFR之间的任何相互作用。令人惊讶的是,我们未能检测到EGFR在HCMV进入成纤维细胞、上皮细胞或内皮细胞系的过程中发挥任何作用。此外,HCMV在成纤维细胞系中未激活EGFR激酶。我们首先研究了HCMV进入两种EGFR阳性或阴性细胞系的情况,但当EGFR高水平表达时,未观察到进入增加。用中和抗体在成纤维细胞、上皮细胞或内皮细胞系中物理阻断EGFR,或用化学抑制剂在成纤维细胞中阻断EGFR激酶信号传导,均未抑制病毒进入。最后,我们未能检测到成纤维细胞中EGFR因HCMV刺激而发生磷酸化。我们的研究结果表明,EGFR在HCMV进入或信号传导中不发挥重要作用。这些结果表明,特定的整合素异二聚体要么单独作为主要的进入受体起作用,要么与除EGFR之外的其他受体结合相互作用,以促进病毒进入。